Hazard Ratio

Type: Keyphrase
Name: Hazard Ratio
First reported 5 hours ago - Updated 5 hours ago - 1 reports

Hormonal Contraceptives Don't Increase HIV Risk, Study Finds

MELBOURNE, Australia — No link between hormonal contraceptives and a woman's risk for HIV has been found after 17 years of follow-up in a Zambian cohort of HIV-discordant couples, new research shows.However, a large meta-analysis shows an increased risk ... [Published General Medicine eJournal - 5 hours ago]
First reported 23 hours ago - Updated 23 hours ago - 1 reports

Efavirenz for Initial Therapy of HIV Associated with Increased Suicide Risk

By Linked ArticlesDifferent antiretroviral medications have different side effect profiles. Efavirenz is a non-nucleoside reverse transcriptase inhibitor widely used to treat HIV. 1 While typically associated with CNS side effects, serious psychiatric ... [Published The AIDS Reader - 23 hours ago]
Entities: Efavirenz, Suicide, HIV/AIDS
First reported Jul 28 2014 - Updated Jul 28 2014 - 1 reports

Celsion Corp announces updated overall survival data from HEAT study of ThermoDox in primary liver cancer

Celsion Corp:Announced updated results from its retrospective analysis of Co's 701-patient HEAT Study of ThermoDox, Celsion's proprietary heat-activated liposomal encapsulation of doxorubicin, in combination with radiofrequency ablation (RFA) in primary ... [Published Reuters - Jul 28 2014]
First reported Jul 25 2014 - Updated Jul 25 2014 - 1 reports

Language barriers don't raise diabetes complication risk

For immigrants, language barriers are not associated with an increased risk of diabetes complications, according to a study published online July 15 in Diabetes Care.(HealthDay)—For immigrants, language barriers are not associated with an increased risk ... [Published Medical Xpress - Jul 25 2014]
First reported Jul 22 2014 - Updated Jul 23 2014 - 4 reports

Breast Cancer Drug Neratanib Meets Trial Goal

Treatment extends disease-free survival versus placeboPositive results have been reported from a phase III clinical study of the investigational drug neratinib (PB272, Puma Biotechnology, Inc.), a pan-ErbB tyrosine kinase inhibitor, for the extended adjuvant ... [Published PT Community - Jul 23 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Weight loss over two years predicts reduced diabetes risk

(HealthDay)—Weight loss over two years is associated with reduced diabetes incidence and improvement in cardiometabolic risk factors, according to a study published online July 14 in Diabetes Care.Linda M. Delahanty, R.D., from Massachusetts General Hospital ... [Published Medical Xpress - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Puma Biotechnology Inc announces positive top line results from Phase III PB272 trial in Adjuvant Breast Cancer (ExteNET Trial)

Puma Biotechnology Inc:Says top line results from Phase III clinical trial of Puma's investigational drug PB272 (neratinib) for extended adjuvant treatment of breast cancer (ExteNET Trial).ExteNET trial is double-blind, placebo-controlled, Phase III trial ... [Published Reuters - Jul 22 2014]
First reported Jul 22 2014 - Updated Jul 22 2014 - 1 reports

Optimal timing for Starting Antiretroviral Therapy in HIV-Infected Patients with Cryptococcal Meningitis

By Linked ArticlesIn most cases, early initiation of antiretroviral therapy after the diagnosis of an opportunistic infection is beneficial. However, starting antiretroviral therapy early in patients with opportunistic infections runs the risk of immune ... [Published The AIDS Reader - Jul 22 2014]
First reported Jul 21 2014 - Updated Jul 21 2014 - 1 reports

Physician continuity is key after ER visit for heart failure

(HealthDay)—Heart failure patients who follow up with a familiar physician after release from the emergency department have better outcomes, according to research published online July 9 in the Journal of the American College of Cardiology: Heart Fai ... [Published Medical Xpress - Jul 21 2014]
First reported Jul 18 2014 - Updated Jul 18 2014 - 1 reports

News Europe Better oral hygiene could improve survival in dialysis patients

Dialysis can allow individuals to live productive and useful lives, even though their kidneys no longer work adequately. (Bild: Picsfive/Shutterstock)LUND, Sweden/AMSTERDAM, the Netherlands: Dialysis patients with poor oral health have a higher mortality ... [Published Dental Tribune - Jul 18 2014]
First reported Jul 16 2014 - Updated Jul 16 2014 - 2 reports

Statins reduce all-cause mortality in chronic obstructive pulmonary disease: a systematic review and meta-analysis of observational studies

ResearchNobuyuki Horita , Naoki Miyazawa , Ryota Kojima , Miyo Inoue , Yoshiaki Ishigatsubo , Atsuhisa Ueda and Takeshi KanekoRespiratory Research 2014, 15 :80doi:10.1186/1465-9921-15-80Published: 16 July 2014Abstract (provisional) BackgroundRecent observational ... [Published Respiratory Research - Jul 16 2014]
First reported Jul 14 2014 - Updated Jul 14 2014 - 1 reports

[In Context] News in brief

Early detection and correct treatment is imperative to prevent secondary stroke due to atrial fibrillation (AF). Current guidelines recommend 24 h of ECG monitoring, but the most effective type and duration of monitoring to detect AF has not been determined. ... [Published The Lancet Neurology - Jul 14 2014]

Quotes

...an STR or once a day now has a history of a safe and tolerable safety profile, studies have just started examine a once a day raltegravir regimen: "First Patient Enrolled in New PhasePhase 3 Trial Program Investigating a Once-Daily Dosing Regimen of ISENTRESS® (raltegravir)" - http://www.natap.org/2014/HIV/060914_10.htm)
"For now, I think physicians are going to adhere to these new guidelines," she told Medscape Medical News . "But they should still emphasize dual methods for high-risk women who are using progestogen-only injectables. Of course, all women at high risk for HIV should be counseled on dual-method use — meaning a modern method of contraception for unintended pregnancy prevention and condoms for HIV prevention."
"It's important for people undergoing a liver transplant to understand how it might affect their entire body, that recovery may be slow and that it may affect them for the rest of their lives" Dr. Samstein said
The review authors agree. For older patients lacking the 17p deletion, "strong consideration should be given to initial treatment with obinutuzumab plus either chlorambucil or bendamustine" they write

More Content

All (308) | News (274) | Reports (0) | Blogs (34) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Raltegravir Regimen More Durable, Atazanavir Le... [Published National AIDS Treatment Advocacy Project - 2 hours ago]
TKIs Combined With Other Drugs May Prove More E... [Published OncLive - 3 hours ago]
Hormonal Contraceptives Don't Increase HIV Risk... [Published General Medicine eJournal - 5 hours ago]
Mania Risk Seen in Treating Bipolar Patients Wi... [Published Psychiatric News - 6 hours ago]
Liver Transplant More Than Just 'Swapping Out a... [Published Diabetes Care - 7 hours ago]
Preexposure Prophylaxis with Tenofovir or Emtri... [Published The AIDS Reader - 7 hours ago]
Treatment for CLL: Change Aplenty, More Coming [Published Diabetes Care - 9 hours ago]
Efavirenz for Initial Therapy of HIV Associated... [Published The AIDS Reader - 23 hours ago]
HIV Prevention at AIDS 2014 - PrEP, TasP, PMTCT... [Published National AIDS Treatment Advocacy Project - Jul 31 2014]
Higher risk of vascular events with polymyalgia... [Published Medical Xpress - Jul 31 2014]
Thyroid Cancer Drug Approved for Accelerated As... [Published Drug Discovery and Development - Jul 31 2014]
European Medicines Agency approves lenvatinib f... [Published Ecancer Medicalscience - Jul 31 2014]
Urinary Albumin-Creatinine Ratio, Estimated Glo... [Published CHEST - Jul 31 2014]
Stage After Chemo Predicts Esophageal Cancer Ou... [Published Diabetes Care - Jul 31 2014]
Diabetes Raises Risk of Head and Neck Cancer [Published Chemotherapy Advisor - Jul 31 2014]
New Data from University of Tokyo Illuminate Fi... [Published HispanicBusiness.com - Jul 31 2014]
JBI's Systematic Reviews: Presenting and Inter... [Published American Journal of Nursing - Jul 31 2014]
EMA Approves Eisai's Lenvatinib for Accelerated... [Published ADVFN UK - Jul 31 2014]
Findings from AstraZeneca Provide New Insights ... [Published 4 Traders - Jul 31 2014]
EMA Approves Eisai's Lenvatinib for Accelerated... [Published OSIX News - Jul 31 2014]
FDA Approves Zydelig for Three Types of Blood C... [Published Pharmacy Practice News - Jul 30 2014]
The Associations between Immunity-Related Genes... [Published Plosone.org - Jul 30 2014]
Video: Nephron sparing vs radical nephrouretere... [Published BJUI - Jul 30 2014]
Fruit, Veg Intake Has Dose-Response Link With C... [Published General Medicine eJournal - Jul 30 2014]
Depressive bipolar patients have highest post-d... [Published MedWire News - Jul 30 2014]
Soaring Sexually Transmitted HCV Rates in Gay/B... [Published The Body PRO - Jul 29 2014]
AIDS 2014: More Data Suggest Increased HIV Risk... [Published HIV and Hepatitis.com - Jul 29 2014]
Infections after cardiac surgery common, with m... [Published Cardiovascular Business - Jul 29 2014]
Obinutuzumab for CLL Approved in EU [Published General Medicine eJournal - Jul 29 2014]
Takeda Receives Positive CHMP Opinions for Labe... [Published Nycomed News RSS feed - Jul 29 2014]
1 2 3 4 5 6 7 8 9 10 ...
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
Takeda Receives Positive CHMP Opinions for Labe... [Published Nycomed News RSS feed - Jul 29 2014]
ZURICH, July 29, 2014 – Takeda Pharmaceuticals International GmbH (“Takeda”) today announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has issued positive opinions for updates ...
A Biotech Stock Is Up Nearly 300% After Announc... [Published Clusterstock - Jul 23 2014]
Shares of Puma Biotechnology are up 296% right now. On Tuesday evening, the company announced encouraging results from its recent breast cancerdrug  trial. "[A] clinical trial of its experimental drug blocked the return of breast cancer in women ...
[In Context] News in brief [Published The Lancet Neurology - Jul 14 2014]
Early detection and correct treatment is imperative to prevent secondary stroke due to atrial fibrillation (AF). Current guidelines recommend 24 h of ECG monitoring, but the most effective type and duration of monitoring to detect AF has not been determined. ...
Multiple sclerosis and psychiatric disorders: C... [Published Multiple Sclerosis Journal RSS feed -- OnlineFi ... - Jul 11 2014]
Background: Psychiatric disorders are known to be prevalent in multiple sclerosis (MS). Objective: The objective of this paper is to study comorbidity between MS and bipolar disorder, schizophrenia and depression in a nationwide cohort and to determine ...
Cranberry versus placebo in the prevention of u... [Published Multiple Sclerosis Journal current issue - Jul 08 2014]
Objective: Our aim was to assess the usefulness of cranberry extract in multiple sclerosis (MS) patients suffering from urinary disorders. Methods: In total, 171 adult MS outpatients with urinary disorders presenting at eight centers were randomized (stratification ...
1 2 3 4 5 6 7
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.